Showing results (31-40 of 373) with videos related to
Sort By:
Pageof 38
British Journal of Cancer|February 24, 2021
Understanding the impact of immune-mediated selection on lung cancer evolutionRachel Rosenthal, Charles Swanton, Nicholas McGranahanExpert Review of Anticancer Therapy|April 21, 2011
Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of actionJames Larkin, Charles Swanton, Lisa PickeringThe EPMA Journal|June 29, 2012
Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneityRosalie Fisher, James Larkin, Charles SwantonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Her2-targeted therapies in non-small cell lung cancerCharles Swanton, Andy Futreal, Tim EisenBiochimica Et Biophysica Acta|April 2, 2015
Inferring mutational timing and reconstructing tumour evolutionary historiesSamra Turajlic, Nicholas McGranahan, Charles SwantonSeminars in Cancer Biology|February 25, 2021
Impact of cancer evolution on immune surveillance and checkpoint inhibitor responseYin Wu, Dhruva Biswas, Charles SwantonThe EMBO Journal|August 30, 2021
Cancer evolution: Darwin and beyondRoberto Vendramin, Kevin Litchfield, Charles SwantonThe Journal of Experimental Medicine|September 16, 2018
Kidney cancer: The next decadeSamra Turajlic, Charles Swanton, Chris BoshoffNature Reviews. Clinical Oncology|January 4, 2018
Determinants and clinical implications of chromosomal instability in cancerLaurent Sansregret, Bart Vanhaesebroeck, Charles SwantonCurrent Cancer Drug Targets|August 20, 2010
Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapiesSarah Barton, Naureen Starling, Charles SwantonPageof 38